Pharmacovigilance in Homoeopathy—Need of the Hour: A Narrative Review

Abstract

Background Homoeopathy is the newest art and science of healing. Like conventional medicine, pharmacovigilance is an important aspect of homoeopathy. There is a paucity of knowledge and ignorance among the practitioners. The necessity is to create awareness and encourage the homoeopathic professionals regarding drug safety surveillance, documentation and reporting of adverse events.

Methods A web-based online search from databases, journals, bibliographic resources regarding the practice of pharmacovigilance in homoeopathy was done. Articles and publications till January 2021 along with literature from homoeopathic books were analysed.

Results Data on adverse drug reactions (ADRs) and events in homoeopathy have been collected and reported in European countries. In India, of late these terminologies are being acknowledged among a group of homoeopathic practitioners only. Still, a dearth of cognizance on the subject exists and little reporting is done. People usually do not relate such adverse reactions to the use of homoeopathic medicines. For scrutinising the same, the Ministry of AYUSH, Govt. of India, has taken an initiative for Pharmacovigilance of Ayurveda, Siddha, Unani & Homoeopathy systems of medicine for reporting and taking measures against ADR and objectionable advertisements. The probable risk factors and ways to prevent ADR and benefits of pharmacovigilance in homoeopathic practice could be deduced.

Conclusion Homoeopathy is a widely followed system of medicine that is quite popular among the common people. The need of knowledge and promotion of suspected ADR reporting should be emphasised to increase the credibility of homoeopathy among the scientific community. Also, the profession should refrain from misleading and objectionable advertisements in print and electronic media.

Keywords

pharmacovigilance - homoeopathy - adverse drug reactions - AYUSH

Publication History

Article published online:
29 May 2022

• References

• 1 Homeopathy: What You Need to Know. National Center for Complementary and Integrative medicine. Accessed December 7, 2021. website https://www.nccih.nih.gov/health/homeopathy
• 2 Cukaci C, Freissmuth M, Mann C, Marti J, Sperl V. Against all odds-the persistent popularity of homeopathy. Wien Klin Wochenschr 2020; 132 (9-10): 232-242
• 3 Edzard E. Reject the pseudoscience of homeopathy. STAT website. https://www.statnews.com/2016/02/26/reject-pseudoscience-homeopathy/ . Accessed December 7, 2021. Published February 26, 2016
• 4 Grams N. Homeopathy-where is the science? A current inventory on a pre-scientific artifact. EMBO Rep 2019; 20 (03) e47761 DOI: 10.15252/embr.201947761.
• 5 Manchanda RK. Building quality research evidence in Homoeopathy. Indian J Res Homoeopathy 2018; 12 (03) 109-112
• 6 Mathie RT. The research evidence base for homeopathy: a fresh assessment of the literature. Homeopathy 2003; 92 (02) 84-91
• 7 Saharan P. Pharmacovigilance & Drug Safety 2020. Am J Adv Drug Deliv 2019;7(03). Accessed December 7, 2021 https://www.imedpub.com/articles/pharmacovigilance–drug-safety2020.php?aid=25981
• 8 Talbot JC, Nilsson BS. Pharmacovigilance in the pharmaceutical industry. Br J Clin Pharmacol 1998; 45 (05) 427-431
• 9 Mammì M, Citraro R, Torcasio G, Cusato G, Palleria C, di Paola ED. Pharmacovigilance in pharmaceutical companies: an overview. J Pharmacol Pharmacother 2013; 4 (Suppl. 01) S33-S37
• 10 World Health Organization. Regulation and prequalification. https://www.who.int/teams/regulation-prequalification/regulation-andsafety/pharmacovigilance/health-professionals-info/pidm Accessed December 7, 2021. Published April 2, 2020
• 11 Mirosevic Skvrce N, Galic I, Pacadi C, Kandzija N, Mucalo I. Adverse drug reactions that arise from the use of medicinal products outside the terms of the marketing authorisation. Res Social Adm Pharm 2020; 16 (07) 928-934
• 12 World Health Organization. The importance of pharmacovigilance. https://apps.who.int/iris/bitstream/handle/10665/42493/a75646.pdf . Accessed December 7, 2021. Published 2002
• 13 Grandjean P. Paracelsus revisited: the dose concept in a complex world. Basic Clin Pharmacol Toxicol 2016; 119 (02) 126-132
• 14 Safety M. Benefits and Risks. Health products regulatory authority website. http://www.hpra.ie/homepage/medicines/safety-information/medicines-safety-benefits-and-risks . Accessed December 7, 2021. Published 2014
• 15 Prakash S. Pharmacovigilance in India. Indian J Pharmacol 2007; 1: 125-128 December 7, 2021
• 16 Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279 (15) 1200-1205
• 17 World Health Organization. WHO global report on traditional and complementary medicine 2019. https://www.who.int/traditional-complementary-integrative-medicine/WhoGlobalReportOnTraditionalAndComplementaryMedicine2019.pdf?ua=1 Accessed December 7, 2021. Published 2019
• 18 Bhalerao MS, Bolshete PM, Swar BD. et al. Use of and satisfaction with complementary and alternative medicine in four chronic diseases: a cross-sectional study from India. Natl Med J India 2013; 26 (02) 75-78 https://pubmed.ncbi.nlm.nih.gov/24093979/ Accessed December 7, 2021
• 19 FDA warns against the use of homeopathic teething tablets and gels. US Food and Drug administration website. https://www.fda.gov/news-events/press-announcements/fda-warns-against-use-homeopathic-teething-tablets-and-gels Accessed December 7, 2021. Published September, 2016
• 20 Roberts HA. Homoeopathy and the Fundamental Laws. The Principles and Art of Cure by Homoeopathy. 3rd edition. New Delhi, India: B. Jain Publishers (P) Ltd; 2005: 45-54
• 21 Hahnemann S. In: O'Reilly WB. ed. Organon of the Medical Art. New Delhi: B. Jain Publishers (P) Ltd; 2010: 225
• 22 Hahnemann S. Organon of the Medicine. 5th edition. New Delhi: B. Jain Publishers (P) Ltd; 2002: 115-181
• 23 Hahnemann S. In: O' Reilly WB. ed. Organon of the Medical Art. New Delhi: B. Jain Publishers (P) Ltd; 2010: 223
• 24 Hahnemann S. In: O' Reilly WB. ed. Organon of the Medical Art. New Delhi: B. Jain Publishers (P) Ltd; 2010: 171
• 25 Stub T, Salamonsen A, Alraek T. Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study. Forsch Komplement Med 2012; 19 (01) 13-19
• 26 Posadzki P, Alotaibi A, Ernst E. Adverse effects of homeopathy: a systematic review of published case reports and case series. Int J Clin Pract 2012; 66 (12) 1178-1188
• 27 Jong MC, Jong MU, Baars EW. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases. Pharmacoepidemiol Drug Saf 2012; 21 (12) 1295-1301
• 28 Jose J, Rao PG, Kamath MS, Jimmy B. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital. J Altern Complement Med 2009; 15 (07) 793-797
• 29 Endrizzi C, Rossi E, Crudeli L, Garibaldi D. Harm in homeopathy: aggravations, adverse drug events or medication errors?. Homeopathy 2005; 94 (04) 233-240
• 30 Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med (Lond) 2016; 16 (05) 481-485
• 31 Hahnemann S. In: O' Reilly WB. ed. Organon of the Medical Art. New Delhi: B. Jain Publishers (P) Ltd; 2010: 169
• 32 Goel S. Origin and Sources of Homoeopathic drugs. Art and Science of Homoeopathic Pharmacy. Third enlarged and revised edition. New Delhi: Indian Books and Periodicals Publishers; 2014: 26-27
• 33 Pharmacovigilance System Mandate for Drug Manufacturers. Aysushsuraksha website. https://www.ayushsuraksha.com/pharmacovigilance-system-mandate-for-drug-manufacturers/ Accessed December 7, 2021. Updated July 14, 2019
• 34 Berreni A, Montastruc F, Bondon-Guitton E. et al. Adverse drug reactions to self-medication: a study in a pharmacovigilance database. Fundam Clin Pharmacol 2015; 29 (05) 517-520
• 35 Kirby BJ. Safety of homeopathic products. J R Soc Med 2002; 95 (05) 221-222
• 36 Woodward KN. The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum Exp Toxicol 2005; 24 (05) 219-233
• 37 Bhadra R, Ravakhah K, Ghosh RK. Herb-drug interaction: The importance of communicating with primary care physicians. Australas Med J 2015; 8 (10) 315-319
• 38 Goel S. Homoeopathic Vehicles and Bases. Art and Science of Homoeopathic Pharmacy. 3rd enlarged and revised edition. New Delhi: Indian Books and Periodicals Publishers; 2014: 73-76
• 39 Ranjit S. Pharmacovigilance and homoeopathy: a review. J Pharamacovigil 2020; 8: 284 DOI: 10.35248/2329-6887.20.8.284.
• 40 Miller RG. Relationships of Remedies and sides of the Body. New Delhi: B. Jain Publishers (P) Ltd; 2008
• 41 Bhat B, Udupa N, Ligade V, Khan S, Sreedhar D. Assessment of knowledge and attitude of patients on herbal medicine use in Udupi Region, Karnataka, India. Trop J Pharm Res 2019; 18 (01) 117 DOI: 10.4314/tjpr.v18i1.17.
• 42 Rajesh B, Dharani R, Waseem A. Assessment of knowledge, attitude, and practice of pharmacovigilance among doctors practicing alternative systems of medicine in Southern India: a questionnaire-based study. Natl J Physiol Pharm Pharmacol 2017; 7 (01) 1 DOI: 10.5455/njppp.2017.7.0824318082016.
• 43 Rajanandh MG, Chamundeeswari D. Need of pharmacovigilance in AYUSH drugs. J Pharmacovigil 2017; 5 (01) e166 DOI: 10.4172/2329-6887.1000e166.
• 44 Rajanandh MG, Chamundeeswari D. Perspectives of pharmacovigilance of AYUSH drugs among health care professionals - a cross-sectional survey. Sri Ramachandra Journal of Medicine 2016; 9 (01) 5-9 https://www.sriramachandra.edu.in/university/pdf/research/journals/perspectives-of.pdf. Accessed December 7, 2021
• 45 Misleading Advertisements Regarding AYUSH Medicines. Aysushsuraksha website. https://www.ayushsuraksha.com/misleading-advertisements-regarding-ayush-medicines/ . Accessed December 7, 2021. Updated July 14, 2019
• 46 Advertisement O. All India Institute of Ayurveda (AIIA) website. https://aiia.gov.in/pharmacovigilance/objectionable-advertisement/ Accessed December 7, 2021. Updated February 21, 2019